Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,995,723
+$201,273 QoQ
Shares Held
23,608
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,483
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $25,445,603 across 11 Drug Manufacturers - General names. JNJ ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,846 | $7,011,868 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
23,608 | $5,995,723 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,899 | $3,456,521 | |
| 4 | AMGN |
Amgen Inc
|
8,535 | $3,090,694 | |
| 5 | ABBV |
AbbVie Inc.
|
10,340 | $2,601,957 | |
| 6 | NVS |
Novartis AG
|
8,050 | $1,261,596 | |
| 7 | PFE |
Pfizer Inc
|
33,525 | $807,282 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,261 | $411,994 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,995,723 | 23,608 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,794,450 | 23,705 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,930,997 | 23,827 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,440,252 | 23,947 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $3,586,722 | 23,481 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,907,356 | 23,561 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,459,165 | 23,919 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,057,982 | 25,040 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,610,444 | 24,702 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,928,015 | 24,831 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,924,926 | 25,041 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,915,243 | 25,138 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,975,128 | 24,016 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,718,140 | 23,988 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,240,483 | 24,005 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,775,086 | 23,109 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $4,060,541 | 22,875 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $4,129,636 | 23,301 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,830,770 | 22,393 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,702,549 | 22,926 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,849,809 | 23,369 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,721,705 | 22,645 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,036,017 | 19,291 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,021,019 | 6,858 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $976,956 | 6,947 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $890,241 | 6,789 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||